Additional file 14 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

  • Antoine H C van Kampen (Contributor)
  • Pernette J. Verschure (Contributor)
  • Simone Borgoni (Contributor)
  • Stefan Wiemann (Contributor)
  • Perry D Moerland (Contributor)
  • Emre Sofyall (Contributor)
  • Maryam Soleimani Dodaran (Contributor)

Dataset / Software

Description

Additional file 14. CpGs with concordant significant changes in the survival and resistance acquisition signatures and with significant correlation between paired DNA methylation and gene expression profiles. CpGs in single-locus (Additional File 4) and multi-locus (Additional File 7) survival signatures were selected according to three additional criteria: (i) CpG DNA methylation is significantly (adjusted p-value
Date made available1 Jan 2020
Publisherfigshare Academic Research System

Access Dataset

Cite this